pleurisy, which is characterized by an extensive inflammatory exudate in the pleural space, is a common manifestation of extrapulmonary tuberculosis caused by Mycobacterium tuberculosis infection but is difficult to diagnose. This study compared concentrations of three cytokines (interferon-g and interleukin [IL]-2 and -4) and soluble Fas ligand in serum and pleural effusions from 36 patients with tuberculous pleurisy, 30 with malignant pleurisy and 30 healthy volunteers. Interferon-g concentration was significantly higher in serum and pleural effusions, and the concentration of soluble Fas ligand was significantly higher in pleural effusion, from patients with tuberculous pleurisy than in those with malignant pleurisy. Levels of IL-2 and IL-4 were also raised in serum, but failed to reach statistical significance. Interferon-g and soluble Fas ligand levels were significantly higher in pleural effusion than in serum. Pleural soluble Fas ligand concentrations correlated linearly with those of interferon-g in patients with tuberculous pleurisy. These findings suggest a predominant T-helper-1 response to M. tuberculosis infection.
Introduction
Tuberculosis remains a major infectious cause of death worldwide. Approximately one-third of the world's population has been infected by Mycobacterium tuberculosis. 1 Tuberculous pleurisy, which is regarded as an inflammatory response to M. tuberculosis in the pleural space (extrapulmonary tuberculosis) and yields extensive inflammatory exudate, 2 is a common manifestation but is difficult to diagnose. 3 Mycobacterial antigens interact with previously sensitized T-lymphocytes and cause an immunological or hypersensitive reaction.
Many inflammatory cells, including neutrophils, mononuclear cells, lymphocytes and mesothelial cells, along with a complex array of cytokines, are involved in local granuloma formation. 4 Interferon-γ, interleukin (IL)-2 and IL-4 are three important cytokines putatively involved in the inflammatory process of tuberculous effusion, and are key factors in H-Y Cui, Q Zang, B Su et al.
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T-cell polarization. In some studies, markedly elevated interferon-γ levels have been noted in tuberculosis compared with in other conditions, but the findings for levels of IL-2 and -4 are less clear-cut. 5, 6 Infection by M. tuberculosis can induce apoptosis in activated T-cells and macrophages, and tuberculous pleurisy has been employed as a model to study this effect at sites of active infection in human patients. 7 Fas ligand (FasL) is a type II membrane protein belonging to the tumour necrosis factor family and induces apoptosis by binding to Fas receptor. This protein, therefore, plays an important part in the regulation of apoptosis of T cells, macrophages and cytokines. 8 The Fas/FasL system is involved in protective immunity against M. tuberculosis. A soluble form of FasL (sFasL) exists in various human body fluids, including serum and pleural effusion. 9 Previous studies have suggested that this form might contribute to the inflammatory process and subsequent tissue damage in patients infected with M. tuberculosis. 7 Much effort has been devoted to clarifying the immune mechanisms related to tuberculosis and to identifying immunologically important factors in the development of tuberculous pleurisy, to improve disease diagnosis, prevention and treatment. Given the compartmentalization of the pleural space, the association between the local and systemic cellular response should be analysed. The present study investigated concentrations of interferon-γ and IL-2 and -4, as well as sFasL, in serum and pleural effusions from patients with tuberculous pleurisy compared with those from patients with malignant pleurisy and healthy volunteers. In addition, the relationships between sFasL and cytokine concentrations were assessed.
Patients and methods

STUDY POPULATION AND DIAGNOSIS
Patients with tuberculous pleurisy or malignant pleurisy caused by lung cancer who were attending Shanghai Pulmonary Hospital, China, and healthy volunteers recruited from subjects attending Shanghai Pulmonary Hospital for a routine check up and found to have no health problems were enrolled into the study from April 2009 to July 2010. Pleural effusion was defined as exudative, according to the criteria of Light et al. 10 Written informed consent was obtained from all participants at enrolment. The Ethics Committee of Shanghai Pulmonary Hospital, China, approved the study.
Tuberculous effusion was diagnosed by one of the following methods: (i) pleural biopsy showing granulomatous inflammation together with stainable acidfast bacilli; (ii) identification of M. tuberculosis in pleural fluid by culture, in pleural fluid or tissue by a positive smear for acid-fast bacilli, or detection of mycobacterial-specific DNA in pleural samples by polymerase chain reaction; or (iii) pleural biopsy showing granulomatous inflammation without stainable acid-fast bacilli but with a good clinical and radiographic response to antituberculosis treatment. A diagnosis of malignant pleurisy caused by lung cancer was made on the basis of malignant cells being present on cytological examination of the pleural fluid.
All healthy volunteers had negative sputum smears and cultures, showed no signs of tuberculosis on chest radiographs and had tuberculin indurations > 10 mm at 72 h on skin testing. The healthy volunteers were required to be negative for human immunodeficiency virus and to have no history of tuberculosis or other systemic autoimmune disorders.
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Before the start of treatment, blood samples were taken into heparin tubes from all patients and healthy controls, and pleural effusion was drawn by sterile thoracentesis from patients in the two pleurisy groups. Sera and pleural effusions were separated by centrifugation, and cell supernatant was separated and stored at -20°C. The levels of cytokines and sFasL in serum and pleural supernatants were measured with commercial enzyme-linked immunosorbent assay kits (R & D Systems; Minneapolis, MN, USA), according to the manufacturer's instructions.
STATISTICAL ANALYSIS
Statistical analysis of the data was carried with the SPSS ® statistical package, version 13.0 (SPSS Inc., Chicago, IL, USA). The median and mean ± SD of the data were calculated. Non-parametric tests were used to analyse variables, since they were not normally distributed. For comparison between tuberculous and malignant pleurisy, the Mann-Whitney U-test was used. The differences between healthy controls and patients were assessed with the Kruskal-Wallis multiple comparisons test, and Wilcoxon's signed rank test was used for paired samples. Correlations between variables were determined by Spearman's rank correlation coefficient. A value of P < 0.05 was deemed significant.
Results
A total of 36 patients with tuberculous pleurisy (age 38 ± 17 years), 30 with malignant pleurisy caused by lung cancer (age 54 ± 11 years) and 30 healthy volunteers (age 45 ± 10 years) were successfully recruited to the study. There was no statistically significant difference in age between the tuberculous pleurisy vs healthy volunteers, however the patients with malignant pleurisy caused by lung cancer differed significantly in age from the tuberculous pleurisy patients and healthy volunteers (P = 0.004 and P = 0.000, respectively), Mean serum concentrations of interferonγ were significantly higher in patients with pleurisy (tuberculous and malignant) than in controls (P = 0.009), but the mean levels of IL-2, IL-4 and sFasL did not differ significantly (Table 1) . Likewise, the mean serum level of interferon-γ, but not of IL-2, IL-4 or sFasL, were significantly higher in patients with tuberculous pleurisy than in those with malignant pleurisy (P = 0.009).
In pleural effusions the mean levels of sFasL and interferon-γ were significantly higher in patients with tuberculous pleurisy than in those with malignant pleurisy (P = 0.012 and P = 0.006, respectively; Table 2 ). In both these groups, the levels of interferon-γ and sFasL were significantly higher in pleural effusions than in serum (P = 0.000, P = 0.000, and P = 0.001, P = 0.000, respectively).
The pleural sFasL concentration correlated linearly with that of interferon-γ in patients with tuberculous pleurisy (r = 0.588, P = 0.000; Fig. 1 ). No statistically significant correlations were found between pleural sFasL concentration and concentrations of IL-2 and IL4 in patients with tuberculous pleurisy (r = 0.330 and 0.193, respectively).
Discussion
The present study showed that interferon-γ and sFasL concentrations were significantly raised in the serum and pleural effusions of patients with tuberculous pleurisy. Previous studies have reported that tuberculous pleurisy predominantly provokes a T-helper (T h )-1 response, whereas malignant pleurisy mainly provokes a T h -2 response. 11 Pleural effusion from patients with tuberculous H-Y Cui, Q Zang, B Su et al. 
Cytokines and Fas ligand levels in pleurisy
H-Y Cui, Q Zang, B Su et al. Cytokines and Fas ligand levels in pleurisy
pleurisy has a high concentration of CD4 + Tcells that are sufficiently activated to promote secretion of cytokines, including interferon-γ and IL-2, the former of which is characteristic of T h 1 immunity. 12 This suggests, therefore, that interferon-γ has an important role in the local immune response. 13 Yang et al. 14 demonstrated that the concentration of interferon-γ in pleural fluid was a useful diagnostic marker for tuberculosis presenting with lymphocytic exudative pleural effusion. The findings of the present study are consistent with these previous studies.
Interleukin 2 and interferon-γ are both released by T h 1 cells and have important roles in the protective immune response. The present study showed that IL-2 levels were raised in the serum of patients with tuberculous pleurisy but this increase failed to reach statistical significance. Levels of IL-2 in serum have previously been reported to be higher in patients with active tuberculosis compared with healthy controls. 15 The concentrations of IL-4 were similar for all groups in serum and pleural effusions in the present study, which supports previous findings for this cytokine. 16, 17 Besides the above-mentioned activation of a T h 1-type response, organisms use multiple mechanisms to prevent M. tuberculosis infection. Activated lymphocytes express FasL on their membranes to eliminate various cells, including macrophages, which results in the destruction of cells infected with M. tuberculosis. 16 Despite the importance of apoptosis in the pathological process, few investigations have been conducted on pleural effusions. The present study showed no difference between the concentration of sFasL in serum from patients with tuberculous pleurisy and that in patients • Revised accepted 10 November 2010 Copyright © 2010 Field House Publishing LLP with malignant pleurisy. By contrast, concentrations of sFasL in pleural effusion were significantly higher in patients with tuberculosis than in those with malignant pleurisy. The linear relationship between sFasL and interferon-γ concentrations in tuberculous pleurisy patients indicated that T-cell apoptosis by the Fas/FasL killing pathway was increased in these patients.
Tuberculosis and malignant disease are two major causes of lymphocyte-dominant pleurisy and the differentiation between them is a critical clinical problem. The diagnosis of pleural tuberculosis is currently based on characteristic histological features in pleural tissue or a positive culture of M. tuberculosis in pleural fluid. The sensitivity of these investigations is, however, limited. In most cases sputum smear and culture are negative. 18, 19 The present study suggests that the measurement of interferon-γ and sFasL might be useful as alternative approaches to conventional diagnostic methods.
In conclusion, the present study demonstrated predominant T h 1 immunity in tuberculous pleurisy and indicated that T-cell apoptosis by the Fas/FasL killing pathway was increased. A significant correlation between the concentrations of interferon-γ and sFasL in tuberculous pleural effusions was also found. Although this study was limited by the small number of patients investigated, these findings might contribute to a further understanding of immune mechanisms in tuberculosis.
